Other
Outcome
Outcome is an intervention with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(3)
Other(2)
Detailed Status
Completed3
unknown2
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Trials by Status
completed360%
unknown240%
Recent Activity
0 active trials
Showing 5 of 5
unknown
Prognostic Value of PtcO2 in Patients With COVID-19
NCT05682612
completed
Therapy and Outcome of Prolonged Veno-venous ECMO Therapy of Critically Ill ARDS Patients.
NCT05338593
unknown
Long Term Outcome of Extracorporeal Membrane Oxygenation Patients in China
NCT03345758
completed
General Surgery Residency Training in Low Income Countries
NCT04689334
completed
Fractures of the Humeral Shaft With Primary Radial Nerve Palsy
NCT03948542
Clinical Trials (5)
Showing 5 of 5 trials
NCT05682612
Prognostic Value of PtcO2 in Patients With COVID-19
NCT05338593
Therapy and Outcome of Prolonged Veno-venous ECMO Therapy of Critically Ill ARDS Patients.
NCT03345758
Long Term Outcome of Extracorporeal Membrane Oxygenation Patients in China
NCT04689334
General Surgery Residency Training in Low Income Countries
NCT03948542
Fractures of the Humeral Shaft With Primary Radial Nerve Palsy
All 5 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 5